Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Cash Conversion Ratio

-4.85×

Quarterly · Period ending: Jun 30, 2026

LCTX Cash Conversion Ratio

Latest reported-4.85×period endingJun 30, 2026

Latest reported-4.85×period endingJun 30, 2026

LCTX Quarterly Cash Conversion Ratio (0.00× → -4.85×)

Latest values, visible window

High-resolution chart · PNG

LCTX cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2001	0.7245×
Mar 31, 2001	1.0647×
Dec 31, 2000	0.8173×
Dec 31, 1999	0.9167×
Sep 30, 1999	0.2174×
Jun 30, 1999	1.4×
Mar 31, 1999	1.5×
Sep 30, 1998	1.0909×
Jun 30, 1998	1.25×
Mar 31, 1998	1.0909×
Dec 31, 1997	2×
Sep 30, 1997	1×
Mar 31, 1997	1.4×
Dec 31, 1996	0.625×
Sep 30, 1996	0.8571×
Mar 31, 1996	-0×
Dec 31, 1995	-0×
Sep 30, 1995	2×
Mar 31, 1995	0.8333×
Dec 31, 1994	1×
Sep 30, 1994	1×
Mar 31, 1994	1×
Dec 31, 1993	1×
Sep 30, 1993	1×
Mar 31, 1993	1.5×
Dec 31, 1992	1×
Sep 30, 1992	1×
Mar 31, 1992	-0×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.